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We report a case of a patient with adrenal failure due to bilateral adrenal metastasis of lung cancer. This is a rare presentation of
lung cancer. We review the diﬀerential diagnosis of weight loss and how to make diagnosis of adrenal insuﬃciency.
1.Introduction
Adrenal failure is a rare condition, and the most common
cause is autoimmune adrenalitis. Other causes include
adrenal destruction by infections such tuberculosis and
fungal disease or cancer metastatic inﬁltration. Lung cancer
is commonly associated with adrenal metastasis, but few
reports show association with adrenal insuﬃciency.
2.CaseReport
A 69-year-old man was admitted to a hospital in the South
of Brazil, with weight loss, weakness, and diﬃculty to
swallow. In the last 4 months, he had anorexia, asthenia,
and diﬃculty to swallow any food. When he tried to eat,
he felt nausea and sometimes vomited. He had lost 7kg.
He denied fever or other symptoms. He was an active
smoker that had smoked 100 pack-years. He did not abuse
alcohol or other drugs. He had arterial hypertension, type
2 diabetes mellitus with HbA1c: 6.5% one month earlier
and mild chronic obstructive pulmonary disease. He had
presented three no disabling ischemic strokes. He was
taking hydrochlorothiazide 25mg, simvastatin 20mg, and
acetylsalicylic acid 100mg, once a day; and captopril 50mg
TID. His father died of sudden death at 83 years old, and
his mother died of stroke at 80 years old. His brother
died of esophageal cancer with 55 years old. He lived with
his wife. His physical examination revealed an alert, ori-
ented man, with blood pressure: 120/70mmHg; heart rate:
72bpm; respiratory rate: 20rpm; axillary temperature: 36◦C;
pulse oximetry: 95%; weight: 33.5kg; height: 1.53m; BMI:
14.3kg/m2. There were several lymph nodes the cervical
region, the larger one with 1.5cm, and digital clubbing.
Other aspects of his physical examination were normal.
Two months before admission, chest radiography showed
signs of chronic obstructive pulmonary disease, micronod-
ules and linear opacities in the upper lobes, and a small
consolidation in the lower left lobe. The initial laboratory
evaluation revealed hemoglobin = 8.6g/dL (normal range:
13–14.2g/dL); VCM = 88.9fL (80–100fL); leukocytes =
7220/μL (4000–10000/μL); neutrophils = 2758/μL (1800–
7500/μL); eosinophils = 606/μL (40–500/μL); basophils =
87/μL( <100/μL); monocytes = 477/μL (120–1000/μL); lym-
phocytes = 3292/μL (1000–4000/μL); platelets: 409000/μL
(150–400 × 103/μL); serum sodium: 134mEq/L (135–
145mEq/L); potassium: 5.2mEq/L (3.5–5.1mEq/L); creati-
nine: 0.64mg/dL (0.5–1.2mg/dL); ureic nitrogen: 21mg/dL
(5–20mg/dL); calcium: 7.8mg/dL (8.5–10.4mg/dL); albu-
min: 3.0g/dL (3.5–5.0g/dL); ALT: 17U/L (<31U/L); glu-
cose: 94/mg/dL (70–99mg/dL). An upper gastrointestinal2 Case Reports in Oncological Medicine
endoscopy was normal, and a nasojejunal tube was inserted.
The patient remained with the same symptoms, receiv-
ing food and liquids through a nasojejunal tube. In the
sixth day after admission, after being submitted to chest
and abdomen computerized tomography, he developed
fever (39.5◦C), confusion, blood pressure 160/110mmHg,
heart rate: 120bpm, pulse oximetry: 95%. He received
intravenous dipyrone. A few moments later, his blood
pressure dropped to 80/40mmHg, and intravenous saline
solution was infused. A blood sample to measure serum
ACTH and cortisol was drawn. In the next two days,
he had no fever, and two samples of blood culture were
negative. In the following days, the patient developed
severe hyponatremia (sodium = 122mEq/L and 119mEq/L),
and postural hypotension was identiﬁed (supine resting =
122/60mmHg and standing = 100/60mmHg). The results
of computed tomography of chest and abdomen are shown
in Figures 1 and 2. Serum cortisol and ACTH were,
respectively, 1.03μg/dL (4.3–22.4μg/dL) and 626pg/mL
(12–46pg/mL), and serum TSH was 8.06μU/mL (0.35–
5.5μU/mL). The patient received intravenous hydrocor-
tisone, and hydrochlorothiazide was discontinued. Elec-
trolyte abnormalities, anorexia, and diﬃculty to swallow
are resolved. A biopsy of the left adrenal gland showed
signet-ring cell adenocarcinoma with areas of necrosis. In
the immunohistochemical study, the cells were positive for
CK7, TTF-1, and CEA, and negative for CK20, vimentin,
CA19.9, CD10, prostatic speciﬁc antigen, and thyroglobulin.
Therefore, the diagnosis of adenocarcinoma of pulmonary
originwasmade.Boneandbrainmetastaseswerenotevident
in bone scintigraphy and brain computerized tomography. A
few days later, the patient was switched to 5mg oral pred-
nisone and 0.1mg of ﬂudrocortisone and was discharged
to his home. One month after initiating glucocorticoids, he
came to the outpatient oncology division. He was eating
normally, his weight increased to 40.1kg, but he refused the
palliative chemotherapy oﬀered.
3. Discussion
Involuntary weight loss often indicates a serious illness [1].
The possibility of cancer should be considered in this case,
especially from the esophagus, considering the diﬃculty to
swallow.
Although the etiology of his weight loss could be
attributed to esophageal cancer, the nonprogressive nature of
his dysphagia is against this hypothesis. Lung cancer should
also be considered because the patient was a heavy smoker
with clubbing, which is a common sign in this particular
cancer [2]. Nevertheless, other causes of weight loss should
be investigated [1]. Infections usually are accompanied by
fever and/or night sweats. Paraneoplastic syndromes, like
hypercalcemia, and hyponatremia could have contributed to
the clinical symptoms. Hypercalcemia could justify anorexia,
nausea, and vomiting but usually is associated with an
inability to concentrate urine, resulting in increased urinary
volume and intestinal constipation [3]. Among the other
endocrine problems associated with weight loss, decompen-
sated diabetes mellitus is improbable, because the patient
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Figure 1: Thoracic computed tomography scan. It showed an
elongated noncalciﬁed image, with irregular contours, measuring
approximately 2.8cm × 1.4cm, in the upper left lobe, contiguous
to an area of pleural thickening, and large areas of emphysema.
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Figure 2: Abdominal computed tomography scan. It showed mas-
sive heterogeneous lesions in both adrenals, measuring about 5cm
in each greatest diameter.
had no polyuria nor polydipsia. Hyperthyroidism should be
investigated, because it can occur in the absence of goiter,
and an apathetic presentation in elders is not unexpected,
with anorexia and depression [4]. Depression, due to its
high prevalence in elders, as well as the use of drugs with
anorexic eﬀects should always be evaluated in patients losing
weight [5–7]. Malabsorption disorders could be the cause of
unexplainedweightloss,butthispatienthadnodiarrheanor
increase in the bulk of feces [8]. Last, but not least, physical
signs of cortisol deﬁciency should be thoroughly searched
for, like postural hypotension and hyperpigmentation, due
to its devastating consequences when undiagnosed.
Esophageal cancer was excluded, but some aspects of
this patient evaluation are worth a closer look. The imagesCase Reports in Oncological Medicine 3
of his chest were deﬁnitely abnormal. He also had anemia,
with normal sized red cells, suggesting no blood loss. He
had a slight increase in eosinophil cells, and the lymphocytes
in the upper end of normal were quite unexpected in
an undernourished patient [9]. Most importantly, he had
mild hyponatremia, mild hyperkalemia, and normal renal
function with an increased serum ureic nitrogen/creatinine
ratio; these abnormalities could be due to captopril use,
but hydrochlorothiazide induces hypokalemia, so hypoal-
dosteronism should be considered as its cause. The major
causes of hypoaldosteronism are aldosterone deﬁciency, as
in Addison’s disease, or resistance; taken together, these data
suggest primary adrenal failure [10].
After a brief episode of hypotension, the possibility of
adrenal failure became stronger, because an episode of sepsis
would not resolve spontaneously. The measurement of his
standingandsupinerestingbloodpressureswouldbehelpful
to identify postural hypotension.
The patient had Addison’s disease. This is a rare disease.
Its diagnosis was based on very low serum cortisol with
increased serum ACTH [11]. The etiology of adrenal failure
is more commonly autoimmune destruction of the glands
in developed countries, but tuberculosis and paracoccid-
ioidomycosis are still prevalent in South Brazil [12, 13]. The
presence of pulmonary nodules and large masses in both
adrenals suggest Addison’s disease secondary to metastatic
destruction of the glands. The increase in serum TSH could
be due to coexistent hypothyroidism or to the cortisol
deﬁciency [14].
Adrenals are commonly involved by metastatic disease,
more commonly from lung, breast, melanoma, colon, and
stomach. It rarely causes adrenal failure because 90% of
the glands should be destroyed to cause adrenal failure
[15].
This case illustrates a common and diﬃcult situation in
clinicalpractice:weightloss.Investigation shouldbedirected
by patient’s signs and symptoms. This patient had diﬃculty
to swallow which points to esophagus cancer or extrinsic
esophagus compression from lung cancer. Other ﬁndings
suggestingcancerwereheavytobaccoconsumptionanddigi-
talclubbing.Anuppergastrointestinalendoscopyandthorax
imaging were performed to investigate these hypotheses.
Laboratory data showed normocytic anemia, mild eos-
inophilia, hyponatremia, and hyperkalemia. These ﬁndings
are consistent with adrenal failure, but this diagnosis was not
considered as the cause of weight loss due to the high chance
of cancer in this patient and the rare association among then.
An adrenal crisis with transitory hypotension, fever, and very
low sodium, after the administration of sodium chloride, has
made the medical team to suspect Addison’s disease. Massive
inﬁltration of the adrenals supported this.
Although a possible primary lung cancer lesion was
found, an ultrasound-guided adrenal biopsy was performed
because of its lower risk of complication. It is interesting to
note that the main cause of weight loss in this patient was
adrenal failure despite a metastatic cancer. Patient promptly
recovered his weight after glucocorticoid replacement.
4.LearningPoints
(1) Involuntary weight loss is usually associated with
medical or psychiatric disorders. It is usually asso-
ciated with increased appetite in hyperthyroidism,
uncontrolled diabetes mellitus, and malabsorption
syndromes. Decreased appetite is common in malig-
nancy, gastrointestinal diseases, like inﬂammatory
bowel disease, metabolic disorders, such as adrenal
failureorhypercalcemia,infectiousdisease,advanced
heart, lung, or kidney diseases, among others.
(2) Common symptoms in chronic primary adrenal fail-
ure are weakness, fatigue, anorexia, and gastrointesti-
nal symptoms like nausea and vomiting. The major
signsareweightloss,hyperpigmentation,andarterial
hypotension. Usual laboratory abnormalities include
hyponatremia and hyperkalemia. Eosinophilia is
found in less than 20% of the cases.
(3) The diagnosis of primary adrenal insuﬃciency
depends upon the demonstration of inappropriately
low cortisol production. Early morning serum cor-
tisol below 3μg/dL with high basal plasma ACTH
levels conﬁrms the diagnosis of adrenal insuﬃciency
and establishs its cause. Short ACTH stimulation
test should be performed when adrenal failure is
suspected and basal tests are not conclusive. Serum
cortisol concentration greater than 18–20μg/dL after
ACTH administration excludes adrenal failure.
(4) Adrenal insuﬃciency is usually caused by autoim-
mune adrenalitis, as part of the polyglandular
autoimmune syndrome, or as a single disease. In
the past, infectious adrenalitis was the main cause
of adrenal failure, and still is a frequent cause in
underdeveloped countries. Infective agents associ-
ated to this condition are tuberculosis, histoplasmo-
sis, paracoccidioidomycosis, and HIV. Hemorrhagic
infarction can be present in meningococcemia or
coagulopathy. Metastatic cancer is a rare cause of
adrenal failure, although metastases to adrenal are
common.
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